Sayonara: Daiichi Sankyo To Sell Sun Stake
This article was originally published in PharmAsia News
Executive Summary
With an announcement that it plans to sell all or part of its stake in Sun Pharma, the Japanese drug maker Daiichi Sankyo is set to retreat from Indian shores, barring a few existing business alliances. The move will likely see the company recover better financial health and greatly ease the burden of handling Ranbaxy’s issues.